The Patent Finder

Proclara Biosciences, Inc.

Also on record
Records under this name other than the patents Proclara Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 6 of 6 · Back to Proclara Biosciences, Inc.

PatentTitleStatus Expires Confidence
US 9,493,515Bacteriophage gene 3 protein compositions and use as amyloid binding agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,493,516Bacteriophage gene 3 protein compositions and use as amyloid binding agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,688,728Bacteriophage gene 3 protein compositions and use as amyloid binding agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,723,951Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,247,055General amyloid interaction motif (GAIM)
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,988,444Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity
Formerly held
Lapsed on the fee record
Ended Jun 5, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2026From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited